NEW YORK, November 10, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding United States Steel Corp. (NYSE: X), Oasis Petroleum Inc. (NYSE: OAS), GoPro, Inc. (NASDAQ: GPRO), Nu Skin Enterprises Inc. (NYSE: NUS) and Philip Morris International, Inc. (NYSE: PM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7811-100free.
United States Steel Corp. Research Reports
On October 30, 2014, United States Steel Corp. (US Steel) issued a press release, informing election of Patricia Diaz Dennis and Robert J. Stevens to the Company's Board of Directors, with effect from January 1, 2015. US Steel stated that Dennis and Stevens will serve as Directors until the next Annual Meeting of Stockholders, which, most likely be held on April 28, 2015. Dennis currently serves on the boards of directors of Massachusetts Mutual Life Insurance Company, Entravision Communications Corporation and National Public Radio. Meanwhile, Stevens, currently serves as lead director of the Monsanto Company, and is a board member of the Congressional Medal of Honor Foundation, the Marine Corps Scholarship Foundation, and the Atlantic Council. The full research reports on US Steel are available to download free of charge at:
Oasis Petroleum Inc. Research Reports
On November 4, 2014, Oasis Petroleum Inc. (Oasis Petroleum) announced its Q3 2014 financial results. The Company posted Q3 2014 net income of $121.6 million, or $1.21 per diluted share, compared with $54.5 million, or $0.59 per share, in the year-ago period. Excluding a gain on derivatives and other one-time items, the Company posted profit of $0.52 per share. Analysts had expected earnings of $0.72 per share, according to Thomson Reuters I/B/E/S. Revenue increased 20.7% YoY to $368.7 million. The Company also managed to increase its average daily production during the quarter to 45,873 barrels of oil equivalent per day (Boepd), an increase of 38.7% YoY and 5% QoQ. For Q4 2014, the Company expects 47.0 to 49.0 MBoepd of average daily production. For full year 2014, the Company lowered its average daily production guidance to 44.9 - 45.4 from 46.0 - 50.0 MBoepd. The full research reports on Oasis Petroleum are available to download free of charge at:
GoPro, Inc. Research Reports
On November 4, 2014, GoPro, Inc. (GoPro) appointed Zander Lurie as the Senior Vice President of Media with immediate effect. In his new role, Lurie will report to GoPro President, Tony Bates, and will provide strategic leadership of the creation, curation and distribution of the world class content now synonymous with GoPro. "We have high aspirations for the next chapter of our content story and Zander is an experienced media leader who will help us expand both our production and programming capabilities," said Bates. Prior to his appointment at GoPro, Lurie served as the Executive Vice President at Guggenheim Digital Media, owner of high-profile brands such as Dick Clark Productions and the Los Angeles Dodgers. The full research reports on GoPro are available to download free of charge at:
Nu Skin Enterprises Inc. Research Reports
On November 5, 2014, shares of multilevel marketer - Nu Skin Enterprises Inc. (Nu Skin) fell to a new 52-week low after the Company reported lower Q3 2014 financial results and also curtailed its Q4 2014 earnings forecast. For Q3 2014, the Company reported a net income of $68.3 million, or $1.12 per diluted share, down from $110.9 million, or $1.80 per diluted share, a year earlier. Nu Skin's revenue fell 29.7% YoY to $638.8 million. Commenting on the outlook, Ritch Wood, CFO of Nu Skin said, "We anticipate the impact from currency on fourth-quarter revenue will be about $50 million when compared to currency rates in the prior-year period and about $30 million sequentially." Consequently, Nu Skin lowered its Q4 2014 revenue forecast to range between $590 million and $610 million from its previous revenue estimates of $650 million to $675 million; and that of EPS to $0.72 and $0.77, down from earlier guidance of $1.00 to $1.05. Nu Skin's shares fell 13.21% to end at $43.76, the same day. The full research reports on Nu Skin are available to download free of charge at:
Philip Morris International, Inc. Research Reports
On November 3, 2014, Philip Morris International, Inc. (PMI) reported that its subsidiaries have received a go-ahead from an English Court to challenge the EU's Tobacco Products Directive (2014/40/EU) before the Court of Justice of the European Union (CJEU). Key questions regarding the Directive's validity will be referred to the CJEU as ordered by Mr. Justice Turner during a hearing at the Royal Courts of Justice. Commenting on the approval, Marc Firestone, Senior Vice President and General Counsel of PMI, said, "This marks an important first step for our challenge of the EU's Tobacco Products Directive. We believe the Directive disrupts the balance that the EU treaties establish between the Union and the Member States, and we are looking forward to a thorough, objective review by the EU's highest court." The full research reports on PMI are available to download free of charge at:
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review